A Drug–Drug Interaction Study of Zanubrutinib with Moderate and Strong CYP3A Inhibitors in Patients with B-Cell Malignancies

Project: Research

Project Details

Project Description

NMA HREC Reference Number: CALHN HREC red R20200607
NMA SSA Reference Number: SSA/70111/MonH-2020-242090(v2)
Monash Health Reference: RES-20-0000-858X
Effective start/end date25/11/2024/11/25


  • clinical trial
  • treatment efficacy
  • treatment safety
  • lymphoma